Company / Total Debt
ARS Pharmaceuticals, Inc. Total Debt History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$96.4M
FY2025
5-year range
$0 / $96.4M
FY2024-FY2025
Trend
-
vs FY2024
Sector context
#61 of 83
Health Care
What the data says
At $96M, ARS Pharmaceuticals, Inc.'s total debt ranks #23 of 83 in the Health Care sector.
Based on SEC 10-K filings.
$96M in FY2025.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#23 of 83 in Health CareTop 27% of 83This company $96.4M Sector average $6.2B
▼
-98.4% below sector average
Key checks
Key Insights
- Ranks #61 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $96.4M | - |
| FY2024 | $0 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026